|
2016 |
Structure-Activity Relationships of [des-Arg(7)]Dynorphin A Analogues at the κ Opioid Receptor. |
Victor Hruby, Ph.D., Tally Largent-Milnes, PhD, Yeon Sun Lee, Frank Porreca, PhD, John M. Streicher, PhD, Todd Vanderah, PhD |
|
2016 |
Identifying postmenopausal women at risk for cognitive decline within a healthy cohort using a panel of clinical metabolic indicators: potential for detecting an at-Alzheimer's risk metabolic phenotype. |
Roberta Diaz Brinton, Ph.D |
|
2016 |
Cyclic non-opioid dynorphin A analogues for the bradykinin receptors. |
Yeon Sun Lee, Frank Porreca, PhD |
|
2016 |
Angiotensin-(1-7)/Mas receptor as an antinociceptive agent in cancer-induced bone pain. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2016 |
Cyclic Opioid Peptides. |
Yeon Sun Lee |
|
2016 |
Sex differences in metabolic aging of the brain: insights into female susceptibility to Alzheimer's disease. |
Roberta Diaz Brinton, Ph.D |
|
2016 |
(S)-Lacosamide inhibition of CRMP2 phosphorylation reduces postoperative and neuropathic pain behaviors through distinct classes of sensory neurons identified by constellation pharmacology. |
Rajesh Khanna, May Khanna, PhD, Amol Patwardhan, M.D., Ph.D., Frank Porreca, PhD, Todd Vanderah, PhD, Yanhua Xie, Ph.D. |
|
2016 |
Biphalin: The Foundation of Bivalent Ligands. |
Yeon Sun Lee |
|
2016 |
Activation of Mitofusin2 by Smad2-RIN1 Complex during Mitochondrial Fusion. |
Nam Lee, Ph.D. |
|
2016 |
Age, APOE and sex: Triad of risk of Alzheimer's disease. |
Roberta Diaz Brinton, Ph.D |
|
2016 |
Sensitization of Ion Channels Contributes to Central and Peripheral Dysfunction in Neurofibromatosis Type 1. |
Rajesh Khanna |
|
2016 |
Highlights From the AM Assoc of Pharmaceutical Scientists/International Transporter Consortium Joint Workshop on Drug Transporters in Absorption, Distribution, Metabolism, and Excretion: From the Bench to the Bedside - Clinical Pharmacology Considerations |
Patrick T Ronaldson, PhD |
|
2016 |
Brain and White Matter Hyperintensity Volumes After 10 Years of Random Assignment to Lifestyle Intervention. |
Roberta Diaz Brinton, Ph.D |
|
2016 |
Various modifications of the amphipathic dynorphin A pharmacophore for rat brain bradykinin receptors. |
Yeon Sun Lee, Frank Porreca, PhD |
|
2016 |
Regulation of gene expression and mitochondrial dynamics by SMAD. |
Nam Lee, Ph.D. |
|
2016 |
Relative vascular permeability and vascularity across different regions of the rat nasal mucosa: implications for nasal physiology and drug delivery. |
Jeffrey J. Lochhead, PhD |
|
2017 |
Targeting the S1P/S1PR1 axis mitigates cancer-induced bone pain and neuroinflammation. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2017 |
Functional Expression of P-glycoprotein and Organic Anion Transporting Polypeptides at the Blood-Brain Barrier: Understanding Transport Mechanisms for Improved CNS Drug Delivery? |
Thomas P Davis, PhD, Patrick T Ronaldson, PhD |
|
2017 |
Targeting a Potassium Channel/Syntaxin Interaction Ameliorates Cell Death in Ischemic Stroke. |
Rajesh Khanna |
|
2017 |
Editorial: The Metabolic-Inflammatory Axis in Brain Aging and Neurodegeneration. |
Roberta Diaz Brinton, Ph.D, Fei Yin, Ph.D. |
|
2017 |
Emerging Roles of Transforming Growth Factor β Signaling in Diabetic Retinopathy. |
Nam Lee, Ph.D. |
|
2017 |
Heat-shock protein 90 (Hsp90) promotes opioid-induced anti-nociception by an ERK mitogen-activated protein kinase (MAPK) mechanism in mouse brain. |
John M. Streicher, PhD |
|
2017 |
Anti-NMDA receptor encephalitis presenting as a primary psychotic disorder. |
Jeffrey J. Lochhead, PhD |
|
2017 |
Role of Transporters in Central Nervous System Drug Delivery and Blood-Brain Barrier Protection: Relevance to Treatment of Stroke. |
Patrick T Ronaldson, PhD |
|
2017 |
Genetic and pharmacological antagonism of NK1 receptor prevents opiate abuse potential. |
Rajesh Khanna, Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
